Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Business Exposures
Activism
Animal Testing
Artificial Intelligence
Boeing 737
Brexit
Cannabis
Censorship
Climate
Coal
COVID-19
Criminal
Death
Debt Markets
Derivatives
Diversity
Economy
Electric Vehicles
Electricity Generation
Ethanol
Financial
Firearms
Fossil Fuels
Glyphosate
Harassement
Immigration
Information Security
Intellectual Property
Interest Rates
Labor
Layoff
Lead
Legal
Palm Oil
Pension
Political
Product Safety
Regulatory
Religion
Securities Market
Supply Chain
Tariff
Textiles
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026
Today 18:30 EDT
Via
NewMediaWire
Topics
Lawsuit
Tickers
BAC
CAPR
Exposures
Financial
Legal
Product Safety
Kaplan Fox Reminds Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Securities Class Action Deadline - Contact the Firm Before September 28, 2026
Today 12:05 EDT
Via
NewMediaWire
Topics
Lawsuit
Tickers
BAC
CAPR
Exposures
Financial
Legal
Product Safety
Astrazeneca Secures FDA Approval for New Breast Cancer Treatment
↗
Today 11:47 EDT
Via
Benzinga
Exposures
Product Safety
Where Will CRISPR Therapeutics Stock Be in 5 Years?
↗
Today 11:20 EDT
Via
The Motley Fool
Tickers
CRSP
VRTX
Exposures
Product Safety
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
Today 10:05 EDT
Via
Investor Brand Network
Tickers
BIIB
BMWYY
QNTM
RHHBY
SNY
Exposures
Product Safety
InvestorNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial
Today 9:25 EDT
Via
Investor Brand Network
Tickers
BIIB
CLNN
CSE:QNTM
QNTM
RHHBY
SNY
Exposures
Product Safety
MissionIRNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Gains Editorial Spotlight Following FDA Clearance for Lucid-MS Phase 2 Trial
Today 9:25 EDT
Via
Investor Brand Network
Tickers
BIIB
CLNN
CSE:QNTM
QNTM
RHHBY
SNY
Exposures
Product Safety
Beam Therapeutics Targets Accelerated FDA Approval for Base-Editing Treatment
↗
Today 9:22 EDT
Via
Benzinga
Exposures
Product Safety
MiniMed (MMED) Q1 2027 Earnings Call Transcript
↗
Today 7:44 EDT
Via
The Motley Fool
Topics
Earnings
Tickers
MMED
Exposures
Financial
Product Safety
Echocardiography Market Size, Trends, and Growth Forecast 2026-2033
↗
Today 7:37 EDT
Via
Talk Markets
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
COVID-19
Product Safety
Helio Peptides Review: Exploring Quality and Research Standards
↗
Today 3:19 EDT
Via
Talk Markets
Topics
Supply Chain
Exposures
Product Safety
Supply Chain
Youth Tobacco Use Is at Historic Lows. Adult Smokers Still Need Better Choices.
Today 0:00 EDT
Via
NewsUSA
Exposures
Product Safety
Maye Musk Recounts 'Strange' Experience With Tesla's Cybercab Without a Steering Wheel And Pedals in 2024 Amid Austin Rollout: 'It Will Free Up…'
↗
September 06, 2026
Via
Benzinga
Topics
Product Recall
Tickers
TSLA
Exposures
Legal
Product Safety
Gilead Sciences Just Won Its Third FDA Approval in Less Than 4 Months. Is the Stock Still Underrating This Turnaround Play?
↗
September 05, 2026
Via
The Motley Fool
Tickers
GILD
Exposures
Product Safety
Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Seek Leadership in a Securities Fraud Lawsuit by September 28, 2026
September 04, 2026
Via
NewMediaWire
Topics
Fraud
Lawsuit
Tickers
BAC
CAPR
Exposures
Financial
Legal
Product Safety
Reliable Dual-Mesh Xanthan Gum for Flexible Food Applications
September 04, 2026
Via
AB Newswire
Exposures
Product Safety
Contact Lens Import Compliance in 2026: A 10-Country Compliance Map from Constar
September 04, 2026
Via
AB Newswire
Exposures
Product Safety
Liang Hesheng released Buddha, Fortune, Affinity, A Three-Piece Red-and-Gold Feng Shui Calligraphy Series
September 04, 2026
Via
Get News
Topics
Product Recall
Exposures
Legal
Product Safety
Why Is Belite Bio Stock Soaring Friday?
↗
September 04, 2026
Via
Benzinga
Exposures
Product Safety
Revolution Medicines Got Its Breakthrough—What Moves It Next?
↗
September 04, 2026
Via
MarketBeat
Tickers
AMGN
LLY
MRK
RHHBY
RVMD
Exposures
Product Safety
Boston Scientific Recalls Spinal Cord Stimulator Leads Over Fracture Risk
↗
September 04, 2026
Via
Benzinga
Topics
Product Recall
Exposures
Legal
Product Safety
Compassion Behavioral Health Publishes New Resource Examining Emerging GLP-1 Research and Alcohol Cravings
September 04, 2026
Via
Press Advantage
Exposures
Product Safety
Ionis Pharmaceuticals Wins FDA Approval for First Alexander Disease Treatment
↗
September 04, 2026
Via
MarketBeat
Tickers
IONS
Exposures
Product Safety
FDA Slams Fresenius Over Leaking Dialysis Bags, Warns of Potentially Life-Threatening Risk
↗
September 04, 2026
Via
Benzinga
Exposures
Product Safety
Ionis Drug Wins FDA Approval as First Alexander Disease Treatment
↗
September 04, 2026
Via
Benzinga
Exposures
Product Safety
Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test
↗
September 04, 2026
Via
The Motley Fool
Topics
Earnings
Tickers
GRAL
Exposures
Financial
Product Safety
Cell Therapy Monitoring Kits Market Demand Grows for Reproducible Measurements
↗
September 04, 2026
Via
Talk Markets
Exposures
Product Safety
External Defibrillators Market: Size, Trends, Growth, and Strategic Outlook
↗
September 04, 2026
Via
Talk Markets
Topics
Economy
Exposures
Product Safety
Supply Chain
Kaplan Fox Alerts Investors of Medline Inc. (NASDAQ: MDLN) to Possible Securities Law Violations
September 03, 2026
Via
NewMediaWire
Tickers
BAC
MDLN
Exposures
Product Safety
Kaplan Fox is Investigating Fulcrum Therapeutics, Inc. (NASDAQ: FULC) for Possible Securities Law Violations
September 03, 2026
Via
NewMediaWire
Tickers
FULC
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.